Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: The Role of Ghrelin in Cancer Cachexia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ghrelin for cancer cachexia was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ghrelin (ghrelin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Cancer Cachexia | Phase 2 | Status: TERMINATED | Results posted: 2017-02-24